Cochrane Review Group
Gynaecology and Fertility
194 systematic reviews in Gynaecology and Fertility ask 2,653 questions. 20% have no studies to answer them, 31.1% rest on very low certainty evidence and 13.8% reach moderate or high certainty.
Reviews
194
Questions
2,653
current versions
No studies
20%
Moderate or high
13.8%
No studies 531 · 20%Ungraded 76 · 2.9%Very low 826 · 31.1%Low 855 · 32.2%Moderate 341 · 12.9%High 24 · 0.9%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Transvaginal biological graft vs native tissue repair Bladder function · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 12.64 [1.6, 100.06] | 2 studies · 143 participants | Very low |
Transvaginal biological graft vs native tissue repair Quality of life · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | no estimate extracted | 3 studies · 112 participants | Very low |
Transvaginal permanent mesh vs native tissue repair Recurrent prolapse on examination (any compartment) · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 0.42 [0.32, 0.55] | 25 studies · 3680 participants | Very low |
Transvaginal permanent mesh vs native tissue repair Quality of life · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | no estimate extracted | 9 studies · 1365 participants | Very low |
Summary of findings table ‐ Metformin vs megestrol Regression of endometrial hyperplasia (with or without atypia) to proliferative, secretory, or atrophic endometrium · endometrial hyperplasia Metformin for endometrial hyperplasia (2024) · Cochrane | OR 4.89 [1.56, 15.32] | 2 studies · 83 participants | Very low |
Summary of findings table ‐ Metformin + megestrol vs megestrol Progression of endometrial hyperplasia to endometrial cancer · endometrial hyerplasia Metformin for endometrial hyperplasia (2024) · Cochrane | OR 7.96 [0.16, 402.02] | 3 studies · 156 participants | Very low |
Summary of findings table ‐ Metformin + megestrol vs megestrol Hysterectomy rate · endometrial hyerplasia Metformin for endometrial hyperplasia (2024) · Cochrane | OR 7.39 [0.15, 372.38] | 2 studies · 72 participants | Very low |
Summary of findings table ‐ Metformin + megestrol vs megestrol Abnormal uterine bleeding ‐ not measured · endometrial hyerplasia Metformin for endometrial hyperplasia (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Metformin + megestrol vs megestrol Health‐related quality of life (HRQoL) ‐ not measured · endometrial hyerplasia Metformin for endometrial hyperplasia (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Metformin + megestrol vs megestrol Adverse effects during treatment · endometrial hyerplasia Metformin for endometrial hyperplasia (2024) · Cochrane | no estimate extracted | 1 study · 8 participants | Very low |
Summary of findings table ‐ Metformin + levonorgestrel (intrauterine system) vs levonorgestrel intrauterine system Regression of endometrial hyperplasia (with or without atypia) to proliferative, secretory, or atrophic endometrium · endometrial hyperplasia Metformin for endometrial hyperplasia (2024) · Cochrane | OR 3.42 [0.13, 88.4] | 1 study · 46 participants | Very low |
Summary of findings table ‐ Metformin + levonorgestrel (intrauterine system) vs levonorgestrel intrauterine system Recurrence of endometrial hyperplasia ‐ not reported · endometrial hyperplasia Metformin for endometrial hyperplasia (2024) · Cochrane | no estimate extracted | NR | No studies |
Reviews 194
Progestogen‐releasing intrauterine systems for heavy menstrual bleeding
CochraneSoF table
19 questions
Number of embryos for transfer following in vitro fertilisation or intra‐cytoplasmic sperm injection
CochraneSoF table
8 questions
Pre‐ and postsurgical medical therapy for endometriosis surgery
CochraneSoF table
18 questions
Tubal flushing for subfertility
CochraneSoF table
18 questions
Surgical treatment of fibroids for subfertility
CochraneSoF table
23 questions
Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation
CochraneSoF table
12 questions
Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome
CochraneSoF table
36 questions
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome
CochraneSoF table
7 questions
Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
CochraneSoF table
63 questions
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
CochraneSoF table
7 questions
Hyaluronic acid in embryo transfer media for assisted reproductive technologies
CochraneSoF table
5 questions
Antioxidants for female subfertility
CochraneSoF table
13 questions
Progestogens or progestogen‐releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy)
CochraneSoF table
14 questions
Regular (ICSI) versus ultra‐high magnification (IMSI) sperm selection for assisted reproduction
CochraneSoF table
5 questions
Laparoscopic surgery for endometriosis
CochraneSoF table
18 questions
Interventions for non‐tubal ectopic pregnancy
CochraneSoF table
10 questions
Levonorgestrel‐releasing intrauterine system for endometrial hyperplasia
CochraneSoF table
13 questions
Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction
CochraneSoF table
14 questions
Granulocyte‐colony stimulating factor administration for subfertile women undergoing assisted reproduction
CochraneSoF table
8 questions
In‐bag manual versus uncontained power morcellation for laparoscopic myomectomy
CochraneSoF table
5 questions
GM‐CSF (granulocyte macrophage colony‐stimulating factor) supplementation in culture media for women undergoing assisted reproduction
CochraneSoF table
8 questions
Combined hormonal contraceptives for heavy menstrual bleeding
CochraneSoF table
21 questions
Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding
CochraneSoF table
27 questions
Cyclical progestogens for heavy menstrual bleeding
CochraneSoF table
12 questions
Endometrial resection and ablation techniques for heavy menstrual bleeding
CochraneSoF table
6 questions